Clinical Trials Browser

INDUSTRY × Advanced Solid Tumor × DOXO-EMCH × Clear all

NCT01673438 2022-02-10

Phase 1b Study to Investigate the Safety and Maximum Tolerated Dose of Aldoxorubicin (INNO-206) Plus Doxorubicin HCL in Subjects With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Advanced Solid Tumor